Back
XOMA 10K Form
Buy
64
XOMA
XOMA
Last Price:
24.99
Seasonality Move:
5.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-07 | 10Q | XOMA/XOMA Quarterly |
2023-08-08 | 10Q | XOMA/XOMA Quarterly |
2023-05-09 | 10Q | XOMA/XOMA Quarterly |
2022-11-03 | 10Q | XOMA/XOMA Quarterly |
2022-08-04 | 10Q | XOMA/XOMA Quarterly |
2022-05-05 | 10Q | XOMA/XOMA Quarterly |
Receive XOMA News And Ratings
See the #1 stock for the next 7 days that we like better than XOMA
XOMA Financial Statistics
Sales & Book Value
Annual Sales: | $4.76M |
---|---|
Cash Flow: | $-3.93M |
Price / Cash Flow: | 0 |
Annual Sales: | $7.71 |
Price / Book: | 3.25 |
Profitability
EPS (TTM): | -4.04000 |
---|---|
Net Income (TTM): | $-40.83M |
Gross Margin: | $0 |
Return on Equity: | -37.57% |
Return on Assets: | -26.93% |
XOMA Earnings Forecast
Key XOMA Financial Ratios
- The Gross Profit Margin over the past 33 years for XOMA is 0.00%.
- The Selling, General & Administrative Expenses for XOMA have been equal to 538.17% of Gross Profit Margin.
- The Research & Development expenses have been 3.01% of Revenue.
- The Interest Expense is -1.39% of Operating Income.
- The Net Earning history of XOMA is -858.15% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 17 years.
XOMA Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | XOMA |
CUSIP: | 98419J |
Website: | xoma.com |
Debt
Debt-to-Equity Ratio: | 1.4 |
---|---|
Current Ratio: | 8.68 |
Quick Ratio: | 8.65 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |